Justin Bowers
Stock Analyst at Deutsche Bank
(2.84)
# 2,798
Out of 5,152 analysts
137
Total ratings
48.5%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Reiterated: Hold | $13 → $17 | $15.37 | +10.61% | 8 | Oct 29, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $188 → $250 | $195.16 | +28.10% | 9 | Oct 29, 2026 | |
| A Agilent Technologies | Initiated Coverage: Buy | $190 | $177.33 | +7.14% | 1 | Oct 26, 2026 | |
| FTRE Fortrea Holdings | Upgraded: Buy | $20 → $25 | $20.50 | +21.95% | 8 | Oct 15, 2026 | |
| ATR AptarGroup | Initiated Coverage: Buy | $150 | $141.67 | +5.88% | 1 | Oct 7, 2026 | |
| STVN Stevanato Group | Initiated Coverage: Hold | $22 | $15.36 | +43.23% | 1 | Oct 7, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $300 → $320 | $333.25 | -3.98% | 13 | Sep 25, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $630 → $720 | $692.74 | +3.94% | 11 | Sep 25, 2026 | |
| CON Concentra Group Holdings Parent | Rated: Buy | $32 → $41 | $41.98 | -2.33% | 3 | Aug 10, 2026 | |
| WAT Waters | Rated: Hold | $350 → $400 | $466.10 | -14.18% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $430 → $535 | $646.87 | -17.29% | 4 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $240 | $228.58 | +5.00% | 11 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $73 | $72.75 | +0.34% | 9 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $6 | $7.38 | -18.70% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $23 | $57.07 | -59.70% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 → $315 | $404.02 | -22.03% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $257.84 | n/a | 16 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 → $175 | $172.67 | n/a | 8 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $70 | $134.93 | n/a | 1 | Sep 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $210.01 | n/a | 1 | Jan 17, 2014 |
Avantor
Oct 29, 2026
Reiterated: Hold
Price Target: $13 → $17
Current: $15.37
Upside: +10.61%
ICON Public Limited Company
Oct 29, 2026
Reiterated: Buy
Price Target: $188 → $250
Current: $195.16
Upside: +28.10%
Agilent Technologies
Oct 26, 2026
Initiated Coverage: Buy
Price Target: $190
Current: $177.33
Upside: +7.14%
Fortrea Holdings
Oct 15, 2026
Upgraded: Buy
Price Target: $20 → $25
Current: $20.50
Upside: +21.95%
AptarGroup
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $150
Current: $141.67
Upside: +5.88%
Stevanato Group
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $22
Current: $15.36
Upside: +43.23%
Charles River Laboratories International
Sep 25, 2026
Rated: Buy
Price Target: $300 → $320
Current: $333.25
Upside: -3.98%
Thermo Fisher Scientific
Sep 25, 2026
Reiterated: Buy
Price Target: $630 → $720
Current: $692.74
Upside: +3.94%
Concentra Group Holdings Parent
Aug 10, 2026
Rated: Buy
Price Target: $32 → $41
Current: $41.98
Upside: -2.33%
Waters
Aug 5, 2026
Rated: Hold
Price Target: $350 → $400
Current: $466.10
Upside: -14.18%
Jul 23, 2026
Reiterated: Hold
Price Target: $430 → $535
Current: $646.87
Upside: -17.29%
Jul 22, 2026
Rated: Buy
Price Target: $270 → $240
Current: $228.58
Upside: +5.00%
Jun 26, 2026
Downgraded: Hold
Price Target: $66 → $73
Current: $72.75
Upside: +0.34%
May 8, 2026
Reiterated: Buy
Price Target: $10 → $6
Current: $7.38
Upside: -18.70%
May 8, 2026
Reiterated: Hold
Price Target: $17 → $23
Current: $57.07
Upside: -59.70%
Feb 13, 2026
Reiterated: Buy
Price Target: $345 → $315
Current: $404.02
Upside: -22.03%
Jul 29, 2025
Reiterated: Buy
Price Target: $260 → $220
Current: $257.84
Upside: n/a
Aug 16, 2024
Reiterated: Buy
Price Target: $155 → $175
Current: $172.67
Upside: n/a
Sep 16, 2019
Initiated Coverage: Hold
Price Target: $70
Current: $134.93
Upside: n/a
Jan 17, 2014
Reiterated: Buy
Price Target: $140
Current: $210.01
Upside: n/a